[
    [
        {
            "time": "",
            "original_text": "长生生物被ST,还有21个跌停在等待,疫苗股走势分化,港资逆向‘抄底’医药板块",
            "features": {
                "keywords": [
                    "长生生物",
                    "ST",
                    "跌停",
                    "疫苗股",
                    "走势分化",
                    "港资",
                    "抄底",
                    "医药板块"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "长生生物被ST,还有21个跌停在等待,疫苗股走势分化,港资逆向‘抄底’医药板块",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]